drugset / Trial / NCT05084573

Continuous Interscalene Block vs Liposomal Bupivacaine After Proximal Humerus Fracture Surgery

NCT05084573 ↗

Phase 3 Unknown 92 enrolled The University of Hong Kong
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to compare the efficacy of continuous interscalene block (CISB) using standard bupivacaine versus a single interscalene injection of liposomal bupivacaine (LB) on pain control following surgical fixation of proximal humerus fractures.

Timeline

Start
2020-08-01
Primary completion
2022-07-31
Completion
2023-03-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 1.33 % Other
Subject Bupivacaine Other / unclassified 10 ml Other
Comparator Standard bupivacaine Unknown 0.2 % Other
Comparator Standard bupivacaine Unknown 0.25 % Other
Comparator Standard bupivacaine Unknown 5 ml Other
Comparator Standard bupivacaine Unknown 10 ml Other
Comparator Standard bupivacaine Unknown 300 ml Other

Indications

No indication recorded.